Business Description
Caregen Co Ltd
ISIN : KR7214370009
Compare
Compare
Traded in other countries / regions
214370.Korea IPO Date
2015-11-17Description
Caregen Co Ltd is in the business of research and marketing of Biomimetic peptides and Growth factors. It also offers customized Biomimetic Peptides and toll manufacturing services. The firm's business areas include research and development, production and supply of active ingredients, production and global distribution of Cosmeceuticals and Medical devices and global operation of hair care center. The company's products include CG-Illugen, CG-Nugenerin, CG-Fibrofillin, CG-EGF etc.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 29.7 | |||||
| Beneish M-Score | -1.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | 6 | |||||
| 3-Year EPS without NRI Growth Rate | 9.3 | |||||
| 3-Year FCF Growth Rate | 28.4 | |||||
| 3-Year Book Growth Rate | 3.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 9.25 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.32 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.09 | |||||
| 9-Day RSI | 33.8 | |||||
| 14-Day RSI | 39.06 | |||||
| 6-1 Month Momentum % | -7.8 | |||||
| 12-1 Month Momentum % | -34.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.95 | |||||
| Quick Ratio | 8.14 | |||||
| Cash Ratio | 5.73 | |||||
| Days Inventory | 279.58 | |||||
| Days Sales Outstanding | 74.24 | |||||
| Days Payable | 34.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.8 | |||||
| Dividend Payout Ratio | 0.95 | |||||
| 3-Year Dividend Growth Rate | 17 | |||||
| Forward Dividend Yield % | 3.8 | |||||
| 5-Year Yield-on-Cost % | 7.54 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 3.73 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.15 | |||||
| Operating Margin % | 46.26 | |||||
| Net Margin % | 43.98 | |||||
| FCF Margin % | -68.57 | |||||
| ROE % | 15.29 | |||||
| ROA % | 13.8 | |||||
| ROIC % | 25.86 | |||||
| ROC (Joel Greenblatt) % | 38.65 | |||||
| ROCE % | 15.49 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.44 | |||||
| Forward PE Ratio | 18.79 | |||||
| PE Ratio without NRI | 25.08 | |||||
| Shiller PE Ratio | 37.54 | |||||
| Price-to-Owner-Earnings | 95.96 | |||||
| PS Ratio | 10.74 | |||||
| PB Ratio | 3.71 | |||||
| Price-to-Tangible-Book | 3.79 | |||||
| Price-to-Operating-Cash-Flow | 39.08 | |||||
| EV-to-EBIT | 21.55 | |||||
| EV-to-EBITDA | 18.79 | |||||
| EV-to-Revenue | 9.97 | |||||
| EV-to-FCF | -14.81 | |||||
| Price-to-Projected-FCF | 3.36 | |||||
| Price-to-Graham-Number | 2.06 | |||||
| Price-to-Net-Current-Asset-Value | 10.61 | |||||
| Price-to-Net-Cash | 22.4 | |||||
| Earnings Yield (Greenblatt) % | 4.64 | |||||
| FCF Yield % | -6.41 | |||||
| Forward Rate of Return (Yacktman) % | 3.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Caregen Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 77,067.311 | ||
| EPS (TTM) (â‚©) | 690 | ||
| Beta | 0.85 | ||
| Volatility % | 47.4 | ||
| 14-Day RSI | 39.06 | ||
| 14-Day ATR (â‚©) | 804.224561 | ||
| 20-Day SMA (â‚©) | 18521 | ||
| 12-1 Month Momentum % | -34.49 | ||
| 52-Week Range (â‚©) | 14850 - 30650 | ||
| Shares Outstanding (Mil) | 48.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Caregen Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Caregen Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Caregen Co Ltd Frequently Asked Questions
What is Caregen Co Ltd(XKRX:214370)'s stock price today?
The current price of XKRX:214370 is â‚©16860.00. The 52 week high of XKRX:214370 is â‚©30650.00 and 52 week low is â‚©14850.00.
When is next earnings date of Caregen Co Ltd(XKRX:214370)?
The next earnings date of Caregen Co Ltd(XKRX:214370) is .
Does Caregen Co Ltd(XKRX:214370) pay dividends? If so, how much?
The Dividend Yield %  of Caregen Co Ltd(XKRX:214370) is 3.8% (As of Today), Highest Dividend Payout Ratio of Caregen Co Ltd(XKRX:214370) was 4.91. The lowest was 0.34. And the median was 0.83. The  Forward Dividend Yield % of Caregen Co Ltd(XKRX:214370) is 3.8%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers